The Commission on Cancer (CoC) has accredited 1,532
programs in the U.S. and Puerto Rico; 402 cancer programs are due for surveys in 2015, and 33 new centers
joined the Accreditation Program in 2014. Of the cancer
programs the CoC surveyed in the first half of 2015, 21
received the Outstanding Achievement Award.
Approximately 75 percent of CoC-accredited cancer
programs participate in the Rapid Quality Reporting
System (RQRS). The CoC Accreditation Committee
recently voted to make RQRS participation a compliance standard in 2017.
A limited launch of the Oncology Medical Home
(OMH) Accreditation program will take place in 20 locations. CoC leaders and staff participated in a summit
sponsored by the Community Oncology Alliance at
the end of October, which brought together payors,
physicians, and other constituents to clarify the OMH
needs of all groups and discuss payment options and
incentives for medical oncology care.
Also in development is a Rectal Cancer Accreditation module. The Rectal Cancer Accreditation Steering
Committee plans to identify six facilities for pilot
A cross-functional workgroup is evaluating
pediatric cancer standards and developing an enhanced set of
standards and pediatric performance measures with an
eye toward providing more value to the existing pediatric program participants and adding new participants
in this category.
Newly diagnosed cancer cases from 2013—including
follow-up data for previous years—were submitted to
the National Cancer Data Base (NCDB) in January 2015
and were used to update the quality reporting tools
for end users throughout 1,500 CoC-accredited cancer
programs in July.
The NCDB Cancer Program Practice Profile Reports
(CP3R) has been expanded to include three new qual-
ity measures and one replacement quality measure.
Two cervical, one non-small cell lung, and one rectal
cancer measure were released in March. CP3R currently
reports 15 quality measures across six sites. Five gyne-
cological measures were released this fall, resulting
in a total of 20 quality measures across seven disease
sites. In addition, the Quality Integration Committee
approved nine new NCDB quality metrics—three blad-
der, one pediatric, and five melanoma.
The NCDB is working to satisfy CMS’ requirements
for becoming a QCDR in 2016. By becoming a QCDR,
the NCDB would enable physicians at CoC-accredited
hospitals to submit data to CMS and participate in the
PQRS. Plans are in place to improve the data submission system used by 1,500 hospitals to submit data to
the NCDB and RQRS.
A total of 102 Cancer Liaison Program (CLP) appointments and six State Chair appointments were processed
this year. State Chair Outstanding Achievement Awards
were presented at the State Chair Town Hall Meeting
at Clinical Congress.
The Advocacy Committee’s focus this year has been
on funding for survivorship care and delivery, reimbursement for patient navigation, clinical research,
access to oncology drugs, National Institutes of Health
(NIH) funding, and cancer quality measurement. With
this committee’s support, the CoC hosted a second
annual legislative briefing on Capitol Hill June 9.
One Voice Against Cancer (OVAC) Lobby Days
took place June 8–9 in Washington, DC, with support
from the CoC. The focus was on encouraging members of Congress to back OVAC’s request to increase
funding for the NIH, the National Cancer Institute
(NCI), and the Centers for Disease Control and Prevention. Other legislation that the CoC has supported
this year includes the Breast Cancer Research Stamp
Reauthorization Act of 2015, the Accelerating Biomedical Research Act, and the American Cures Act; the
Advocacy Committee is monitoring the status of the
21st Century Cures Act.
The Clinical Research Program (ACS CRP) Education
Committee sponsored four Panel Sessions and two
The CRP published the first edition of Operative Standards
for Cancer Surgery in July 2015. Five disease site teams
have been developed to research and write the second
edition, targeted for completion in November 2016.